Compounds > tyrosine

tyrosine and Craniofacial Dysarthrosis

tyrosine has been researched along with Craniofacial Dysarthrosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alessandri, JL; Arnaud, E; Balu, M; Collet, C; Daire, VC; Di Rocco, F1
Cai, T; Ge, M; Ke, R; Lei, J; Mu, X; Wu, Y; Yang, J1
Aisa, MC; Baroni, T; Bellocchio, S; Bellucci, C; Bodo, M; Carinci, F; Carinci, P; Conte, C; Lilli, C; Rinaldi, E; Scapoli, L; Stabellini, G; Tosi, L1
Darvann, T; Morriss-Kay, G; Ornitz, DM; Perlyn, CA; Tenenbaum, M1

Other Studies

4 other study(ies) available for tyrosine and Craniofacial Dysarthrosis

ArticleYear
Crouzon syndrome and Bent bone dysplasia associated with mutations at the same Tyr-381 residue in FGFR2 gene.
    Clinical genetics, 2014, Volume: 85, Issue:6

    Topics: Adult; Asparagine; Bone Diseases, Developmental; Child, Preschool; Craniofacial Dysostosis; Female; Humans; Male; Mutation, Missense; Receptor, Fibroblast Growth Factor, Type 2; Tyrosine

2014
Severe meningeal calcification in a Crouzon patient carrying a mutant C342W FGFR2.
    The Journal of craniofacial surgery, 2015, Volume: 26, Issue:2

    Topics: Amino Acid Substitution; Animals; Calcinosis; Child; Craniofacial Dysostosis; Cystine; DNA Mutational Analysis; Female; Genetic Carrier Screening; Humans; Meninges; Mutation; Phenotype; Receptor, Fibroblast Growth Factor, Type 2; Tyrosine

2015
Basic fibroblast growth factor: effects on matrix remodeling, receptor expression, and transduction pathway in human periosteal fibroblasts with FGFR2 gene mutation.
    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2002, Volume: 22, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Adolescent; Cathepsin B; Craniofacial Dysostosis; Endopeptidases; Extracellular Matrix; Fibroblast Growth Factor 2; Fibroblasts; Fibronectins; GRB2 Adaptor Protein; Humans; Kallikreins; Periosteum; Phosphorylation; Plasminogen Activators; Point Mutation; Proteins; Receptors, Fibroblast Growth Factor; Signal Transduction; Tyrosine

2002
A model for the pharmacological treatment of crouzon syndrome.
    Neurosurgery, 2006, Volume: 59, Issue:1

    Topics: Animals; Cranial Sutures; Craniofacial Dysostosis; Cysteine; Disease Models, Animal; Mice; Mice, Mutant Strains; Mutation; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Tissue Culture Techniques; Tomography, X-Ray Computed; Tyrosine

2006